Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel

Sivan Gazit, Yaki Saciuk, Galit Perez, Asaf Peretz, Virginia E. Pitzer, Tal Patalon
doi: http://doi.org/10.1101/2022.03.24.22272835

Article Information

doi 
http://doi.org/10.1101/2022.03.24.22272835
History 
  • March 24, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sivan Gazit, MD, MA1,2,*,
  2. Yaki Saciuk, MPH MA1,
  3. Galit Perez, MN MA2,
  4. Asaf Peretz, MD3,
  5. Virginia E. Pitzer, ScD3 and
  6. Tal Patalon, MD1,2
  1. 1Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel
  2. 2Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Israel
  3. 3Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University; New Haven, CT USA
  1. ↵*Corresponding author. Correspondence to: Sivan Gazit, gazit_s{at}mac.org.il, 27 HaMared street, Tel Aviv, 68125, Israel
Back to top
Posted March 24, 2022.
Download PDF
Data/Code
Email
Relative Effectiveness of Four Doses Compared to Three Dose of the BNT162b2 Vaccine in Israel
Sivan Gazit, Yaki Saciuk, Galit Perez, Asaf Peretz, Virginia E. Pitzer, Tal Patalon
medRxiv 2022.03.24.22272835; doi: http://doi.org/10.1101/2022.03.24.22272835
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area